Belgium and Netherlands initiated a unique international pilot project Belgium-Netherlands Funding of International Trials (BeNeFIT) to carry out non-commercial practice-oriented comparative clinical studies

Dec 2017

In the end of November, the Belgian Health Care Knowledge Centre (KCE) and the Netherlands Organisation for Health Research and Care innovation (ZonMw) signed an agreement to invest 6 million euros for Belgium-Netherlands Funding of International Trials (BeNeFIT). This Belgium-Netherlands collaboration is aimed to carry out non-commercial practice-oriented comparative studies that should be performed by Belgian and Dutch institutions. Only non-commercial organisations can submit a proposal. Additionally, Belgian and Dutch institutions will be invited to submit proposals for research work in January, 2018. The approved research will be carry out by at least two Belgian and two Dutch institutions.

Following studies are considered eligible for funding:

Research of different types of technologies (medicines, medical devices, diagnostic tests and surgery) that are currently in use and eligible for reimbursement
Research of two treatment options for comparison (including active treatment, placebo or no treatment)

Following studies are not considered for funding:

Implementation research
Studies on the organisation of Health Care (Health services Research)
Ongoing studies and studies that are currently recruiting of participants
Studies on new interventions and innovation

See full information in English here.

Subscribe to our newsletter delivered every second week not to miss important reimbursement information.

The latest related news

Rapid HTAs of five medical devices released in Tuscany

Mar 2022

The HTA body of the Tuscany Regional Healthcare issues two types of documents: HTA forms and motivational forms. With a regional decree 2472 of February 10, 2022, Tuscany Regional Healthcare has published assessments of five medical devices of various therapeutic areas, such as cardiovascular and peripheral vascular areas.

Belgian KCE developing procedure for assessment of digital health technologies

Mar 2022

The Belgian Health Care Knowledge Center (KCE) initiated a study aimed at defining a clear and transparent procedure for the evaluation of digital health technologies in Belgium.

Assessments of monitoring and diagnostics of atrial fibrillation products released in Sweden

Mar 2022

On February 07, 2022, the Dental and Pharmaceutical Benefits Agency has announced the withdrawal of the assessments of the PhysioMem PM 100 and CardioMem CM 100 XT and the finalization of the assessments of the Zenicor ECG, Coala Heart Monitor Pro, and KardiaMobile. For the conducted assessments, it was outlined that the portable devices provide more limited information than standard ECG measurements; therefore, it was mainly estimated for atrial fibrillation.

HTAs published by FinCCHTA in February 2022

Mar 2022

In February 2022, the Finnish Coordinating Center for Health Technology Assessment announced the release of the seven accomplished rapid hospital assessments performed by the Helsinki, Tampere, and Oulu University Hospital. The accomplished rapid HTAs concern the diagnostic imaging, e-Health, endocrine, endoscopy, men’s health, neuromodulation technology groups.

Theme survey on products for monitoring and diagnostics of sepsis launched by Swedish TLV

Mar 2022

At the end of February 2022, the Dental and Pharmaceutical Benefits Agency (TLV) has launched a theme survey on products for monitoring and diagnostics of sepsis to identify products that may be relevant for health economic assessments at TLV. The suggestions for the products of interest, ongoing clinical studies, or innovation projects could be received until 23 March 2022.